Increased fracture risk was particularly dangerous during the first two weeks after therapy, when the relative risk was seven times higher than patients in patients on a short-acting opioid.
After the initial two week period, the fracture risk associated with short-acting opioids dropped off but still remained greater than with NSAID therapy.
Read the Internal Medicine News report on short-acting opioids.
Read more on anesthesia:
–Maryland Anesthesiologist Arrested for Alleged Narcotic Distribution
–FDA Accepts Drug Application for Postsurgical Pain Management
–Blocking Receptor Might Help Control Post-Surgery Pain or Inflammation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
